Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease

Lignende værker

• Donor Age Influences Graft-Versus-Host Disease Relapse-Free Survival after Allogeneic Stem Cell Transplant in Elderly Patients in Two Countries from Latin America
  af: Mariano Berro, et al.
  Udgivet: (2023-10-01)
• Hematopoietic stem cell transplantation from an infected SARS-CoV2 haploidentical donor: A case report
  af: Xin Chen, et al.
  Udgivet: (2023-01-01)
• Proceeding of the European Group for Blood and Marrow Transplantation (EBMT) congress on sickle cell disease, 16–17 may 2019, Regensburg, Germany What is the impact of antithymocyte globulin pharmacokinetics on haploidentical hematopoietic stem cell transplantation?
  af: Lisa V.E. Oostenbrink, et al.
  Udgivet: (2020-04-01)
• Early Myeloid Derived Suppressor Cells (eMDSCs) Are Associated With High Donor Myeloid Chimerism Following Haploidentical HSCT for Sickle Cell Disease
  af: Deepali K. Bhat, et al.
  Udgivet: (2021-11-01)
• Utilization of donor CLL-1 CAR-T cells for the treatment of relapsed of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation
  af: Meng Zhang, et al.
  Udgivet: (2025-01-01)